{
    "Trade/Device Name(s)": [
        "GSP Neonatal Total Galactose kit"
    ],
    "Submitter Information": "Wallac Oy, a subsidiary of PerkinElmer Inc.",
    "510(k) Number": "K133652",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071649"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JIA"
    ],
    "Summary Letter Date": "April 14, 2014",
    "Summary Letter Received Date": "April 15, 2014",
    "Submission Date": "April 28, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1310"
    ],
    "Regulation Name(s)": [
        "Galactose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total galactose",
        "Galactose",
        "Galactose-1-phosphate"
    ],
    "Specimen Type(s)": [
        "Blood specimens dried on filter paper",
        "Dried blood spot"
    ],
    "Specimen Container(s)": [
        "Filter paper"
    ],
    "Instrument(s)/Platform(s)": [
        "GSP instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Fluorescent galactose oxidase method"
    ],
    "Methodologies": [
        "Enzymatic determination",
        "Fluorescence detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Reagent",
        "Calibrator",
        "Control",
        "Buffer",
        "Solution",
        "Extraction kit"
    ],
    "Document Summary": "FDA 510(k) summary for GSP Neonatal Total Galactose kit using a fluorescent galactose oxidase enzymatic assay to quantify total galactose in dried blood spots for newborn galactosemia screening.",
    "Indications for Use Summary": "Quantitative determination of total galactose (galactose and galactose-1-phosphate) concentrations in blood specimens dried on filter paper as an aid in screening newborns for galactosemia using the GSP instrument.",
    "fda_folder": "Clinical Chemistry"
}